Merck completes € 180 million investment to expand Schnelldorf Distribution Center
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
The HD21 study adds to the body of evidence supporting ADCETRIS as a backbone agent in the treatment of specific lymphomas
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
New solvent-free micronization technology expanded at the Darmstadt site in Germany
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
This acquisition enables MTD to open new, strategic markets
Subscribe To Our Newsletter & Stay Updated